Clinical trial
Trigger Point Injections for Myofascial Pain: A Comparative Study of Dry Needling, Lidocaine, and Mepivacaine
NCT07079449 is registered in ClinicalTrials.gov with Sümer Münevveroğlu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Trigger Point Injections for Myofascial Pain: A Comparative Study of Dry Needling, Lidocaine, and Mepivacaine
- Lead sponsor
- Sümer Münevveroğlu
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 1, 2025
- Completion date
- August 4, 2025
- Enrollment
- 75 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
facial pain, myofascial pain syndrome, temporomandibular joint disorders